Gene-specific effects of inflammatory Cytokines on cytochrome P4502C, 2B6 and 3A4 mRNA levels in human Hepatocytes

被引:393
作者
Aitken, Alison E. [1 ]
Morgan, Edward T. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
关键词
D O I
10.1124/dmd.107.015511
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochromes P450 ( P450s) are down-regulated in hepatocytes in response to inflammation and infection. This effect has been extensively studied in animal models, but significantly less is known about responses in humans and even less about responses in the absence of inducing agents. This article focuses on the effects of bacterial lipopolysaccaride (LPS), interleukin-6 (IL-6), tumor necrosis factor-alpha( TNF), interferon gamma (IFN), transforming growth factor-beta (TGF) and interleukin- 1 beta ( IL-1) on expression of CYP2B6 and the CYP2C mRNAs in human hepatocytes. These effects were compared with responses of the better studied and more abundant CYP3A4. CYP3A4 and CYP2C8 were down-regulated by all cytokine treatments. CYP2C18, which is expressed at very low levels in liver, was unaffected by cytokine treatments. The other CYP2Cs and CYP2B6 showed cytokine-specific effects. CYP2C9 and CYP2C19 showed almost identical response patterns, being down-regulated by IL-6 and TGF but not significantly affected by LPS, TNF, IFN, or IL-1. CYP2B6 mRNA responded only to IL-6 and IFN. IL-6 down-regulated the mRNAs of all P450s studied. Western blot analysis of P450 protein expression supported the mRNA data to a large extent, although some inconsistencies were observed. Our results show that human CYP2C8, 2C9, 2C18, 2C19, 2B6, and 3A4 responses to inflammation are independently regulated and indicate that this fine control may have a critical effect on human drug responses in disease states.
引用
收藏
页码:1687 / 1693
页数:7
相关论文
共 40 条
[1]  
ABDELRAZZAK Z, 1994, MOL PHARMACOL, V46, P1100
[2]  
ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
[3]   INTERLEUKIN-1-BETA ANTAGONIZES PHENOBARBITAL INDUCTION OF SEVERAL MAJOR CYTOCHROMES P450 IN ADULT-RAT HEPATOCYTES IN PRIMARY CULTURE [J].
ABDELRAZZAK, Z ;
CORCOS, L ;
FAUTREL, A ;
GUILLOUZO, A .
FEBS LETTERS, 1995, 366 (2-3) :159-164
[4]   Regulation of drug-metabolizing enzymes and transporters in inflammation [J].
Aitken, AE ;
Richardson, TA ;
Morgan, ET .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :123-149
[5]   Involvement of interleukin-6 and tumor necrosis factor α in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver [J].
Ashino, T ;
Oguro, T ;
Shioda, S ;
Horai, R ;
Asano, M ;
Sekikawa, K ;
Iwakura, Y ;
Numazawa, S ;
Yoshida, T .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (07) :707-714
[6]   Interleukin-1β inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance [J].
Assenat, E ;
Gerbal-Chaloin, S ;
Larrey, D ;
Saric, J ;
Fabre, JM ;
Maurel, P ;
Vilarem, MJ ;
Pascussi, JM .
HEPATOLOGY, 2004, 40 (04) :951-960
[7]   Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response [J].
Beigneux, AP ;
Moser, AH ;
Shigenaga, JK ;
Grunfeld, C ;
Feingold, KR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (01) :145-149
[8]   Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure [J].
Carcillo, JA ;
Doughty, L ;
Kofos, D ;
Frye, RF ;
Kaplan, SS ;
Sasser, H ;
Burckart, GJ .
INTENSIVE CARE MEDICINE, 2003, 29 (06) :980-984
[9]   Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin [J].
Cheng, PY ;
Wang, ML ;
Morgan, ET .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :1205-1212
[10]  
Donato MT, 1998, J PHARMACOL EXP THER, V284, P760